Manjinder S Lall
Publication Activity (10 Years)
Years Active: 2020-2022
Publications (10 Years): 10
Publications (10 Years): 10
Pfizer Global Research and Development
University of Alberta (PHD)
Affiliation History
Pfizer Global Research and Development
Jun 01 2002
United States
Education History
University of Alberta
Sep 02 1995
- May 30 2000
Canada
Publications
- Xinkun Ren, Bo M Couture, Ningyu Liu, Manjinder S Lall, Jeffrey T Kohrt, Rudi Fasan
- Xinkun Ren, Bo M Couture, Ningyu Liu, Manjinder S Lall, Jeffrey T Kohrt, Rudi Fasan
- Xinkun Ren, Bo M Couture, Ningyu Liu, Manjinder S Lall, Jeffrey T Kohrt, Rudi Fasan
- Xinkun Ren, Bo M Couture, Ningyu Liu, Manjinder S Lall, Jeffrey T Kohrt, Rudi Fasan
- Xinkun Ren, Bo M Couture, Ningyu Liu, Manjinder S Lall, Jeffrey T Kohrt, Rudi Fasan
- Xinkun Ren, Bo M Couture, Ningyu Liu, Manjinder S Lall, Jeffrey T Kohrt, Rudi Fasan
- Xinkun Ren, Bo M Couture, Ningyu Liu, Manjinder S Lall, Jeffrey T Kohrt, Rudi Fasan
- Xinkun Ren, Bo M Couture, Ningyu Liu, Manjinder S Lall, Jeffrey T Kohrt, Rudi Fasan
- Xinkun Ren, Bo M Couture, Ningyu Liu, Manjinder S Lall, Jeffrey T Kohrt, Rudi Fasan
- Manjinder S Lall, Asser Bassyouni, James Bradow, Maria Brown, Mark Bundesmann, Jinshan Chen, Gregory Ciszewski, Anne E Hagen, Dennis Hyek, Stephen Jenkinson, Bo Liu, R Scott Obach, Senliang Pan, Usa Reilly, Neal Sach, Daniel J Smaltz, Douglas K Spracklin, Jeremy Starr, Melissa Wagenaar, Gregory S WalkerLate-Stage Lead Diversification Coupled with Quantitative Nuclear Magnetic Resonance Spectroscopy to Identify New Structure-Activity Relationship Vectors at Nanomole-Scale Synthesis: Application to Loratadine, a Human Histamine H1 Receptor Inverse Agonist. Journal of medicinal chemistry 63 (13) (2020)